Cysteine addiction in drug resistant glioblastoma and therapeutic targeting with designer selenium compounds.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Neuro-Oncology

• Publication date

  2025-11-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/neuonc/noaf265PMID 41212520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidative stress induced protein aggregation via GGCT produced pyroglutamic acid in drug resistant glioblastoma

  2025cited by this paper
• The human zinc-binding cysteine proteome.

  2024cited by this paper
• Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes.

  2024cited by this paper
• TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation

  2024cited by this paper
• Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles.

  2024cited by this paper
• Ebselen analogues delay disease onset and its course in fALS by on-target SOD-1 engagement

  2024cited by this paper
• DrugMap: A quantitative pan-cancer analysis of cysteine ligandability.

  2024cited by this paper
• Histone H3.1 is a chromatin-embedded redox sensor triggered by tumor cells developing adaptive phenotypic plasticity and multidrug resistance

  2024cited by this paper
• Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective.

  2024cited by this paper
• Phenotypic switching as a non-genetic mechanism of resistance predicts antibody therapy regimens

  2024cited by this paper
• The GAPDH redox switch safeguards reductive capacity and enables survival of stressed tumour cells

  2023cited by this paper
• ROS production by mitochondria: function or dysfunction?

  2023cited by this paper
• Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies.

  2023cited by this paper
• Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway.

  2023cited by this paper
• Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)

  2023cited by this paper
• Iron Chelators in Treatment of Iron Overload

  2022cited by this paper
• A Class of Disulfide Compounds Suppresses Ferroptosis by Stabilizing GPX4.

  2022cited by this paper
• Assigning functionality to cysteines by base editing of cancer dependency genes

  2022cited by this paper
• Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts

  2022cited by this paper
• Reaction-based fluorogenic probes for detecting protein cysteine oxidation in living cells

  2022cited by this paper
• Chaperone-Directed Ribosome Repair after Oxidative Damage

  2022cited by this paper
• Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications.

  2022cited by this paper
• Survival Outcomes and Prognostic Factors in Glioblastoma

  2022cited by this paper
• IL-9/STAT3/fatty acid oxidation–mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity

  2022cited by this paper
• Multiplexed proteomic profiling of cysteine reactivity and ligandability in human T cells

  2021cited by this paper
• PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress

  2021cited by this paper
• Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomas

  2021cited by this paper
• Astrocyte-neuron metabolic cooperation shapes brain activity.

  2021cited by this paper
• Development of ebselen for the treatment of sensorineural hearing loss and tinnitus.

  2021cited by this paper
• A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging.

  2020cited by this paper
• Cysteine depletion induces pancreatic tumor ferroptosis in mice

  2020cited by this paper
• Role of Selenoproteins in Redox Regulation of Signaling and the Antioxidant System: A Review

  2020cited by this paper
• Redox regulation of tumor suppressor PTEN in cell signaling

  2020cited by this paper
• Neuroprotective and anti-neuroinflammatory properties of ebselen derivatives and their potential to inhibit neurodegeneration.

  2020cited by this paper
• SOD1, more than just an antioxidant.

  2020cited by this paper
• FSP1 is a glutathione-independent ferroptosis suppressor

  2019cited by this paper
• Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy

  2018cited by this paper
• The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation

  2018cited by this paper
• Proteome-wide analysis of cysteine oxidation reveals metabolic sensitivity to redox stress

  2018cited by this paper
• Functional characterization of lysosomal interaction of Akt with VRK2

  2018cited by this paper
• On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death

  2017cited by this paper
• Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

  2017cited by this paper
• Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma

  2017cited by this paper
• The Different Mechanisms of Cancer Drug Resistance: A Brief Review

  2017cited by this paper
• Molecular Basis for Redox Activation of Epidermal Growth Factor Receptor Kinase.

  2016cited by this paper
• Auranofin: Repurposing an Old Drug for a Golden New Age

  2015cited by this paper
• Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR

  2015cited by this paper
• Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

  2015cited by this paper
• ROS function in redox signaling and oxidative stress.

  2014cited by this paper
• Thioredoxin and Thioredoxin Target Proteins: From Molecular Mechanisms to Functional Significance

  2013cited by this paper
• Redox regulation in stem-like cancer cells by CD44 variant isoforms

  2013cited by this paper
• Cysteine-Mediated Redox Signaling: Chemistry, Biology, and Tools for Discovery

  2013cited by this paper
• Ferroptosis: an iron-dependent form of nonapoptotic cell death.

  2012cited by this paper
• Rational Incorporation of Selenium into Temozolomide Elicits Superior Antitumor Activity Associated with Both Apoptotic and Autophagic Cell Death

  2012cited by this paper
• A Potent, Versatile Disulfide-Reducing Agent from Aspartic Acid

  2012cited by this paper
• A safe lithium mimetic for bipolar disorder

  2012cited by this paper
• In vivo mapping of hydrogen peroxide and oxidized glutathione reveals chemical and regional specificity of redox homeostasis.

  2011cited by this paper
• Cysteine sulfenic acid as an intermediate in disulfide bond formation and nonenzymatic protein folding.

  2010cited by this paper
• Conformational and Oligomeric Effects on the Cysteine pKa of Tryparedoxin Peroxidase

  2010cited by this paper
• Profiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies

  2009cited by this paper
• Regulation of glutathione synthesis.

  2009cited by this paper
• Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry

  2009cited by this paper
• Importance of the trans-sulfuration pathway in cancer prevention and promotion

  2007cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Exploiting the 21st amino acid—purifying and labeling proteins by selenolate targeting

  2004cited by this paper
• Bioavailability of selenium from fish, yeast and selenate: a comparative study in humans using stable isotopes

  2004cited by this paper
• Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors.

  2004cited by this paper
• Integrins and Coagulation: A Role for ROS/Redox Signaling?

  2004cited by this paper
• Active sites of thioredoxin reductases: Why selenoproteins?

  2003cited by this paper
• Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation.

  1998cited by this paper
• Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite.

  1997cited by this paper

• A machine learning-based model for the prediction of thyroid eye disease with oxidative stress-related biomarkers.

  2025cites this paper